Title:
FERRITIN PROTEIN STRUCTURE DISPLAYING SARS-COV-2 S1-DERIVED PROTEIN AND ANTIBODY FC REGION PROTEIN SIMULTANEOUSLY ON SURFACE, AND USE THEREOF FOR VACCINE FOR CORONAVIRUS SARS-COV-2
Document Type and Number:
WIPO Patent Application WO/2024/085723
Kind Code:
A1
Abstract:
The present application relates to a protein structure and a use thereof for a vaccine for prevention or treatment of coronavirus SARS-CoV-2 infectious disease, the protein structure comprising: a first recombinant protein having a SARS-CoV-2 spike protein S1-derived protein and a ferritin heavy chain protein connected; and a second recombinant protein having an antibody Fc region protein and a ferritin light chain protein connected.
Inventors:
SHIN HYUN-JIN (KR)
Application Number:
PCT/KR2023/016390
Publication Date:
April 25, 2024
Filing Date:
October 20, 2023
Export Citation:
Assignee:
IAC IN NAT UNIV CHUNGNAM (KR)
International Classes:
C07K14/005; A61K39/215; A61P31/14; C07K14/47
Domestic Patent References:
| WO2022073138A1 | 2022-04-14 |
Foreign References:
| KR20220133633A | 2022-10-05 | |||
| KR20220133631A | 2022-10-05 | |||
| KR20220107151A | 2022-08-02 |
Other References:
KALATHIYA UMESH, PADARIYA MONIKABEN, FAHRAEUS ROBIN, CHAKRABORTI SOUMYANANDA, HUPP TED R.: "Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages", BIOMOLECULES, vol. 11, no. 297, XP055974833, DOI: 10.3390/biom11020297
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: